Overview

Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex

Status:
Completed
Trial end date:
2008-01-28
Target enrollment:
Participant gender:
Summary
Study aimed to evaluate the efficacy and tolerance of Lazolex®, an emollient gel, to treat mucocutaneous lesions caused by herpes simplex virus.
Phase:
Phase 2
Details
Lead Sponsor:
Iveriapharma LLC